WCMM Fellow Launches Biotech Startup Advancing Bone Cancer Research
Dhalion Biotech, a new WCMM spin-off, is transforming bone cancer research. Founded by WCMM Fellow Paul Bourgine and his team, the startup uses human bone organoids to develop advanced tools for cancer modeling and drug testing. WCMM Fellow Paul Bourgine, alongside co-founders Dimitra Zacharaki and Alejandro García García, both researchers in his group, has launched Dhalion Biotech, an innovative
https://www.wcmm.lu.se/article/wcmm-fellow-launches-biotech-startup-advancing-bone-cancer-research - 2025-10-21
